Source link : https://www.newshealth.biz/health-news/eu-backs-drug-to-relieve-itching-in-alagille-syndrome/
A drug to treat severe itching in patients with Alagille syndrome should be granted a marketing authorization in the European Union under what the European Medicines Agency (EMA) termed exceptional circumstances. At its monthly meeting, the agency’s Committee for Medicinal Products for Human Use (CHMP) determined that Kayfanda (odevixibat; Ipsen Pharma) is clinically effective for […]
Author : News Health
Publish date : 2024-07-26 15:39:23
Copyright for syndicated content belongs to the linked Source.
inHealth